PriceTargets.com logo

Avantor - AVTR Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $14.42
  • Forecasted Upside: 29.53%
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 11 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$11.14 As of 12/4/2025 04:59 PM ET
▼ -0.155 (-1.37%)

This chart shows the closing price for AVTR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Avantor Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AVTR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AVTR

Analyst Price Target is $14.42
▲ +29.53% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Avantor in the last 3 months. The average price target is $14.42, with a high forecast of $18.00 and a low forecast of $12.00. The average price target represents a 29.53% upside from the last price of $11.14.

This chart shows the closing price for AVTR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 15 polled investment analysts is to hold stock in Avantor. This rating has held steady since April 2025, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 11 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 7 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 5 buy ratings
  • 10 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 4 buy ratings
  • 11 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 11 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/4/2025Raymond James FinancialDowngradeOutperform ➝ Market Perform
10/30/2025UBS GroupSet Target$12.00
10/30/2025Evercore ISILower TargetOutperform ➝ Outperform$16.00 ➝ $14.00
10/30/2025BarclaysReiterated RatingOverweight ➝ Equal Weight$15.00 ➝ $12.00
10/30/2025JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$14.00 ➝ $12.00
10/24/2025Robert W. BairdBoost TargetOutperform ➝ Outperform$15.00 ➝ $17.00
10/16/2025Raymond James FinancialBoost TargetOutperform ➝ Outperform$14.00 ➝ $16.00
10/2/2025BarclaysBoost TargetOverweight ➝ Overweight$13.00 ➝ $15.00
8/4/2025Stifel NicolausSet TargetHold ➝ Hold$14.00 ➝ $12.00
8/4/2025JPMorgan Chase & Co.Lower TargetOverweight ➝ Overweight$17.00 ➝ $14.00
8/4/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$15.00 ➝ $12.00
8/4/2025Evercore ISILower TargetOutperform ➝ Outperform$18.00 ➝ $16.00
8/4/2025Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$20.00 ➝ $17.00
8/4/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$19.00 ➝ $16.00
8/4/2025BarclaysReiterated RatingOverweight ➝ Overweight$15.00 ➝ $13.00
8/4/2025Raymond James FinancialSet TargetOutperform ➝ Outperform$16.00 ➝ $14.00
8/4/2025Robert W. BairdLower TargetOutperform ➝ Outperform$18.00 ➝ $15.00
8/1/2025Jefferies Financial GroupReiterated RatingBuy ➝ Hold
7/28/2025Robert W. BairdBoost TargetOutperform ➝ Outperform$17.00 ➝ $18.00
4/29/2025Morgan StanleyDowngradeOverweight ➝ Equal Weight
4/29/2025The Goldman Sachs GroupDowngradeBuy ➝ Neutral$23.00 ➝ $14.00
4/28/2025CowenDowngradeBuy ➝ Hold
4/28/2025Morgan StanleySet TargetOverweight ➝ Equal Weight$25.00 ➝ $15.00
4/28/2025Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$24.00 ➝ $20.00
4/28/2025BarclaysLower TargetOverweight ➝ Overweight$18.00 ➝ $15.00
4/28/2025TD CowenDowngradeBuy ➝ Hold$15.50
4/28/2025Stifel NicolausDowngradeBuy ➝ Hold$26.00 ➝ $14.00
4/28/2025Robert W. BairdLower TargetOutperform ➝ Outperform$21.00 ➝ $17.00
4/17/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$25.00 ➝ $22.00
4/10/2025BarclaysLower TargetOverweight ➝ Overweight$23.00 ➝ $18.00
3/18/2025CowenReiterated RatingBuy ➝ Buy
3/4/2025CitigroupLower TargetNeutral ➝ Neutral$22.00 ➝ $18.00
2/10/2025Morgan StanleyLower TargetOverweight ➝ Overweight$27.00 ➝ $25.00
2/10/2025Raymond James FinancialReiterated RatingOutperform ➝ Outperform$26.00 ➝ $24.00
2/10/2025Royal Bank Of CanadaLower TargetOutperform ➝ Outperform$33.00 ➝ $31.00
2/10/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$28.00 ➝ $25.00
2/10/2025Stifel NicolausLower TargetBuy ➝ Buy$28.00 ➝ $26.00
2/10/2025BarclaysLower TargetOverweight ➝ Overweight$26.00 ➝ $23.00
2/3/2025BarclaysBoost TargetOverweight ➝ Overweight$25.00 ➝ $26.00
1/21/2025Raymond James FinancialLower TargetOutperform ➝ Outperform$29.00 ➝ $26.00
1/17/2025UBS GroupReiterated RatingBuy ➝ Neutral$29.00 ➝ $25.00
10/28/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$30.00 ➝ $28.00
10/28/2024Robert W. BairdLower TargetOutperform ➝ Outperform$27.00 ➝ $26.00
10/25/2024BarclaysLower TargetOverweight ➝ Overweight$28.00 ➝ $25.00
10/8/2024UBS GroupLower TargetBuy ➝ Buy$30.00 ➝ $29.00
9/26/2024Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$34.00 ➝ $34.00
8/27/2024Wells Fargo & CompanyInitiated CoverageOverweight$30.00
7/29/2024Morgan StanleyBoost TargetOverweight ➝ Overweight$28.00 ➝ $29.00
7/29/2024TD CowenBoost TargetBuy ➝ Buy$28.00 ➝ $31.00
7/29/2024BarclaysBoost TargetOverweight ➝ Overweight$25.00 ➝ $28.00
7/29/2024Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$31.00 ➝ $31.00
7/29/2024Stifel NicolausBoost TargetBuy ➝ Buy$27.00 ➝ $28.00
7/29/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$26.00 ➝ $27.00
7/15/2024Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$30.00 ➝ $31.00
7/10/2024CitigroupDowngradeBuy ➝ Neutral$30.00 ➝ $23.00
7/2/2024Evercore ISILower TargetOutperform ➝ Outperform$28.00 ➝ $27.00
6/28/2024BarclaysLower TargetOverweight ➝ Overweight$28.00 ➝ $25.00
4/29/2024Robert W. BairdLower TargetOutperform ➝ Outperform$27.00 ➝ $26.00
4/18/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$23.00 ➝ $25.00
4/10/2024BarclaysBoost TargetOverweight ➝ Overweight$27.00 ➝ $30.00
4/4/2024Evercore ISIBoost TargetOutperform ➝ Outperform$26.00 ➝ $28.00
2/15/2024UBS GroupBoost TargetBuy ➝ Buy$25.00 ➝ $29.00
2/15/2024CitigroupBoost TargetBuy ➝ Buy$24.00 ➝ $30.00
2/15/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$26.00 ➝ $29.00
2/15/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$25.00 ➝ $26.00
2/15/2024Royal Bank Of CanadaBoost TargetOutperform ➝ Outperform$28.00 ➝ $29.00
2/15/2024BarclaysBoost TargetOverweight ➝ Overweight$24.00 ➝ $27.00
1/26/2024Raymond James FinancialBoost TargetOutperform ➝ Outperform$22.50 ➝ $26.00
1/9/2024Royal Bank Of CanadaReiterated RatingOutperform ➝ Outperform$28.00
1/4/2024Evercore ISIUpgradeIn-Line ➝ Outperform$19.50 ➝ $26.00
12/13/2023Wolfe ResearchInitiated CoveragePeer Perform
12/12/2023Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$20.00 ➝ $22.00
12/11/2023BarclaysBoost TargetOverweight ➝ Overweight$21.00 ➝ $24.00
12/11/2023TD CowenUpgradeMarket Perform ➝ Outperform$21.00 ➝ $28.00
12/7/2023The Goldman Sachs GroupBoost TargetBuy ➝ Buy$23.00 ➝ $26.00
10/30/2023Morgan StanleyLower TargetOverweight ➝ Overweight$24.00 ➝ $22.00
10/30/2023BarclaysLower TargetOverweight ➝ Overweight$25.00 ➝ $21.00
10/30/2023Raymond James FinancialLower TargetOutperform ➝ Outperform$25.00 ➝ $22.50
9/29/2023BarclaysBoost TargetOverweight ➝ Overweight$23.00 ➝ $25.00
9/28/2023Sanford C. BernsteinInitiated CoverageMarket Perform$22.00
7/31/2023Royal Bank Of CanadaBoost TargetOutperform$27.00 ➝ $28.00
7/31/2023Morgan StanleyLower TargetOverweight ➝ Overweight$26.00 ➝ $24.00
7/31/2023Raymond James FinancialLower TargetOutperform$28.00 ➝ $25.00
7/31/2023Evercore ISIDowngradeOutperform ➝ Inline$22.00 ➝ $21.00
7/31/2023Robert W. BairdLower TargetOutperform ➝ Outperform$24.00 ➝ $22.00
7/31/2023William BlairDowngradeOutperform ➝ Market Perform
7/31/2023BarclaysBoost TargetOverweight$22.00 ➝ $23.00
7/30/2023Bank of AmericaLower TargetBuy$27.00 ➝ $24.00
6/21/2023Royal Bank Of CanadaInitiated CoverageOutperform$27.00
5/1/2023888Reiterated RatingMaintains
5/1/2023Robert W. BairdLower Target$27.00 ➝ $24.00
5/1/2023BarclaysLower Target$25.00 ➝ $22.00
4/30/2023Bank of AmericaLower Target$30.00 ➝ $27.00
4/4/2023BarclaysLower TargetOverweight$28.00 ➝ $25.00
2/8/2023Wells Fargo & CompanyBoost TargetOverweight$25.00 ➝ $28.00
2/6/2023Raymond James FinancialBoost TargetOutperform$26.00 ➝ $30.00
2/6/2023Robert W. BairdLower Target$29.00 ➝ $27.00
2/6/2023CitigroupBoost TargetBuy$25.00 ➝ $30.00
1/24/2023BarclaysBoost TargetOverweight$23.00 ➝ $26.00
1/10/2023Wells Fargo & CompanyLower TargetOverweight$27.00 ➝ $25.00
12/13/2022Deutsche Bank AktiengesellschaftInitiated CoverageHold$24.00
11/4/2022UBS GroupLower Target$33.00
11/1/2022CowenLower Target$26.00
10/31/2022Raymond James FinancialLower TargetOutperform$27.00 ➝ $26.00
10/31/2022Morgan StanleyLower TargetOverweight$30.00 ➝ $28.00
10/31/2022CitigroupLower Target$28.00 ➝ $25.00
10/31/2022Robert W. BairdLower TargetOutperform$32.00 ➝ $29.00
10/31/2022Wells Fargo & CompanyLower TargetOverweight$33.00 ➝ $27.00
10/31/2022Credit Suisse GroupLower TargetNeutral$32.00 ➝ $25.00
10/31/2022BarclaysLower TargetOverweight$25.00 ➝ $23.00
10/25/2022Morgan StanleyLower TargetOverweight$37.00 ➝ $30.00
10/18/2022Raymond James FinancialLower TargetOutperform$36.00 ➝ $27.00
10/13/2022The Goldman Sachs GroupLower TargetBuy$37.00 ➝ $32.00
10/6/2022Robert W. BairdLower TargetOutperform$35.00 ➝ $32.00
10/6/2022BarclaysLower TargetOverweight$30.00 ➝ $25.00
10/5/2022CitigroupUpgradeNeutral ➝ Buy$28.00
9/19/2022Stifel NicolausLower Target$35.00 ➝ $28.00
9/15/2022UBS GroupLower Target$42.00
9/15/2022KeyCorpLower TargetOverweight$51.00 ➝ $40.00
9/14/2022CowenDowngradeOutperform ➝ Market Perform$39.00 ➝ $28.00
9/14/2022CitigroupLower TargetNeutral$32.00 ➝ $28.00
9/14/2022CowenDowngradeOutperform ➝ Market Perform$39.00 ➝ $28.00
9/12/2022BarclaysLower TargetOverweight$33.00 ➝ $30.00
8/24/2022Credit Suisse GroupInitiated CoverageNeutral$32.00
8/9/2022BarclaysLower Target$33.00
8/9/2022Evercore ISILower Target$35.00
8/9/2022CowenLower Target$39.00
8/1/2022BarclaysLower TargetOverweight$37.00 ➝ $33.00
8/1/2022Raymond James FinancialLower TargetOutperform$40.00 ➝ $36.00
8/1/2022Robert W. BairdLower TargetOutperform$44.00 ➝ $34.00
8/1/2022CitigroupLower TargetNeutral$38.00 ➝ $32.00
8/1/2022Morgan StanleyLower TargetOverweight$40.00 ➝ $37.00
7/14/2022The Goldman Sachs GroupLower TargetBuy$42.00 ➝ $37.00
7/13/2022BarclaysLower TargetOverweight$40.00 ➝ $37.00
4/29/2022William BlairReiterated RatingOutperform
4/25/2022Wells Fargo & CompanyLower TargetOverweight$42.00 ➝ $33.00
4/19/2022CowenLower Target$50.00 ➝ $44.00
4/19/2022CowenLower Target$50.00 ➝ $44.00
4/18/2022Raymond James FinancialLower TargetOutperform$43.00 ➝ $40.00
4/4/2022Evercore ISILower TargetOutperform ➝ Outperform$44.00 ➝ $42.00
4/4/2022CitigroupDowngradeBuy ➝ Neutral$48.00 ➝ $38.00
2/7/2022Morgan StanleyLower TargetOverweight$46.00 ➝ $43.00
2/7/2022Raymond James FinancialLower TargetOutperform$47.00 ➝ $43.00
2/7/2022Robert W. BairdLower Target$44.00 ➝ $43.00
2/7/2022BarclaysBoost TargetOverweight$41.00 ➝ $44.00
1/27/2022BarclaysLower TargetOverweight$48.00 ➝ $41.00
12/9/2021CowenBoost TargetOutperform ➝ Outperform$48.00 ➝ $50.00
11/22/2021JPMorgan Chase & Co.Initiated CoverageOverweight
11/1/2021Raymond James FinancialBoost TargetOutperform$45.00 ➝ $47.00
11/1/2021The Goldman Sachs GroupReiterated RatingBuy$46.00
11/1/2021CitigroupBoost TargetBuy$45.00 ➝ $48.00
11/1/2021Robert W. BairdBoost TargetOutperform$41.00 ➝ $44.00
11/1/2021BarclaysBoost TargetOverweight$43.00 ➝ $48.00
10/14/2021CowenLower TargetOutperform$62.00 ➝ $47.00
9/10/2021Stifel NicolausBoost TargetBuy$43.00 ➝ $46.00
9/10/2021Credit Suisse GroupBoost TargetOutperform$47.00 ➝ $50.00
9/9/2021KeyCorpBoost TargetOverweight$45.00 ➝ $51.00
8/30/2021Raymond James FinancialInitiated CoverageOutperform$45.00
8/2/2021Truist FinancialBoost TargetBuy$35.00 ➝ $45.00
8/2/2021Morgan StanleyBoost TargetOverweight$38.00 ➝ $44.00
8/2/2021CitigroupBoost TargetBuy$40.00 ➝ $45.00
8/2/2021BarclaysBoost TargetOverweight$40.00 ➝ $43.00
8/2/2021Piper SandlerUpgradeNeutral ➝ Overweight$40.00 ➝ $45.00
7/30/2021Credit Suisse GroupBoost TargetOutperform$39.00 ➝ $42.00
7/30/2021Wells Fargo & CompanyBoost TargetOverweight$36.00 ➝ $44.00
7/30/2021KeyCorpBoost TargetOverweight$40.00 ➝ $45.00
6/4/2021The Goldman Sachs GroupInitiated CoverageBuy$40.00
4/29/2021Credit Suisse GroupBoost TargetOutperform$37.00 ➝ $39.00
4/29/2021Raymond James FinancialBoost TargetOutperform$34.00 ➝ $37.00
4/29/2021Morgan StanleyBoost TargetOverweight$35.00 ➝ $38.00
4/29/2021JPMorgan Chase & Co.Boost TargetOverweight$35.00 ➝ $40.00
4/29/2021Robert W. BairdBoost TargetOutperform$32.00 ➝ $36.00
4/29/2021Piper SandlerBoost TargetNeutral$28.00 ➝ $32.00
4/29/2021Stifel NicolausUpgradeHold ➝ Buy$40.00
3/8/2021BarclaysInitiated CoverageOverweight$33.00
3/2/2021BarclaysInitiated CoverageOverweight$33.00
2/4/2021CitigroupBoost Target$33.00 ➝ $35.00
2/4/2021Credit Suisse GroupBoost TargetOutperform$33.00 ➝ $34.00
2/4/2021Morgan StanleyBoost TargetOverweight$27.00 ➝ $35.00
2/4/2021Piper SandlerBoost TargetNeutral$21.00 ➝ $28.00
1/19/2021KeyCorpBoost TargetOverweight$33.00 ➝ $40.00
1/12/2021Raymond James FinancialBoost TargetOutperform$30.00 ➝ $34.00
12/16/2020Smith Barney CitigroupBoost Target$28.00 ➝ $33.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.38 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 22 very positive mentions
  • 20 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
Mentions as of
8/6/2025
  • 51 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 27 very positive mentions
  • 12 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 33 very positive mentions
  • 57 positive mentions
  • 9 negative mentions
  • 2 very negative mentions
Mentions as of
11/4/2025
  • 36 very positive mentions
  • 127 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 36 very positive mentions
  • 127 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Avantor logo
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Read More

Today's Range

Now: $11.14
Low: $10.97
High: $11.33

50 Day Range

MA: $12.68
Low: $10.89
High: $15.61

52 Week Range

Now: $11.14
Low: $10.82
High: $23.32

Volume

8,739,006 shs

Average Volume

7,631,528 shs

Market Capitalization

$7.59 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93

Frequently Asked Questions

What sell-side analysts currently cover shares of Avantor?

The following sell-side analysts have issued stock ratings on Avantor in the last twelve months: Barclays PLC, Citigroup Inc., Cowen Inc, Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Morgan Stanley, Raymond James Financial, Inc., Robert W. Baird, Royal Bank Of Canada, Stifel Nicolaus, TD Cowen, The Goldman Sachs Group, Inc., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for AVTR.

What is the current price target for Avantor?

0 Wall Street analysts have set twelve-month price targets for Avantor in the last year. Their average twelve-month price target is $14.42, suggesting a possible upside of 29.5%. Citigroup Inc. has the highest price target set, predicting AVTR will reach $18.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $12.00 for Avantor in the next year.
View the latest price targets for AVTR.

What is the current consensus analyst rating for Avantor?

Avantor currently has 11 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AVTR, but not buy more shares or sell existing shares.
View the latest ratings for AVTR.

What other companies compete with Avantor?

Other companies that are similar to Avantor include Agilent Technologies, Danaher, Thermo Fisher Scientific, Teradyne and Veralto. Learn More about companies similar to Avantor.

How do I contact Avantor's investor relations team?

Avantor's physical mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The company's listed phone number is (610) 386-1700 and its investor relations email address is [email protected]. The official website for Avantor is www.avantorsciences.com. Learn More about contacing Avantor investor relations.